Mayumi Saeki

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28

Hironobu Minami, Kimie Sai, Mayumi Saeki et al. · Pharmacogenetics and Genomics · 2007 · 285 citations

Haplotypes ofCYP3A4 and their close linkage withCYP3A5 haplotypes in a Japanese population

Hiromi Fukushima‐Uesaka, Yoshiro Saito, Hidemi Watanabe et al. · Human Mutation · 2003 · 165 citations

RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN

Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno et al. · Drug Metabolism and Disposition · 2004 · 144 citations

Glucuronidation of 7-Ethyl-10-hydroxycamptothecin (SN-38), an Active Metabolite of Irinotecan (CPT-11), by Human UGT1A1 Variants, G71R, P229Q, and Y486D

Hideto Jinno, Toshiko Tanaka‐Kagawa, Nobumitsu Hanioka et al. · Drug Metabolism and Disposition · 2003 · 115 citations

Polymorphisms in the ABCC2 (cMOAT/MRP2) Gene Found in 72 Established Cell Lines Derived from Japanese Individuals: An Association between Single Nucleotide Polymorphisms in the 5′-Untranslated Region and Exon 28

Masaya Itoda, Yoshiro Saito, Akiko Soyama et al. · Drug Metabolism and Disposition · 2002 · 91 citations